{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:15:41Z","timestamp":1723043741691},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00520-013-1744-4","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T01:00:37Z","timestamp":1360803637000},"page":"1885-1891","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes in critically ill chronic lymphocytic leukemia patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Ali\u00e9nor","family":"Xhaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Epelboin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Malphettes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0749-0704(18)30511-6","volume":"4","author":"GC Carlon","year":"1988","unstructured":"Carlon GC (1988) Admitting cancer patients to the intensive care unit. Crit Care Clin 4:183\u2013191","journal-title":"Crit Care Clin"},{"key":"1744_CR2","first-page":"317","volume":"12","author":"AR Lloyd-Thomas","year":"1986","unstructured":"Lloyd-Thomas AR, Dhaliwal HS, Lister TA et al (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 12:317\u2013324","journal-title":"Intensive Care Med"},{"key":"1744_CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.1998.16.2.761","volume":"16","author":"JS Groeger","year":"1998","unstructured":"Groeger JS, Lemeshow S, Price K et al (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761\u2013770","journal-title":"J Clin Oncol"},{"key":"1744_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0025-6196(12)61310-X","volume":"67","author":"B Afessa","year":"1992","unstructured":"Afessa B, Tefferi A, Hoagland HC et al (1992) Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 67:117\u2013122","journal-title":"Mayo Clin Proc"},{"key":"1744_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/CCO.0b013e32832b68b6","volume":"21","author":"M Darmon","year":"2009","unstructured":"Darmon M, Azoulay E (2009) Critical care management of cancer patients: cause for optimism and need for objectivity. Curr Opin Oncol 21:318\u2013326","journal-title":"Curr Opin Oncol"},{"key":"1744_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2110-5820-1-5","volume":"1","author":"E Azoulay","year":"2011","unstructured":"Azoulay E, Soares M, Darmon M et al (2011) Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 1:5","journal-title":"Ann Intensive Care"},{"key":"1744_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e3181c0349e","volume":"38","author":"M Soares","year":"2010","unstructured":"Soares M, Caruso P, Silva E et al (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38:9\u201315","journal-title":"Crit Care Med"},{"key":"1744_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00003246-200301000-00017","volume":"31","author":"DD Benoit","year":"2003","unstructured":"Benoit DD, Vandewoude KH, Decruyenaere JM et al (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31:104\u2013112","journal-title":"Crit Care Med"},{"key":"1744_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1378\/chest.94.1.99","volume":"94","author":"SG Peters","year":"1988","unstructured":"Peters SG, Meadows JA 3rd, Gracey DR (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94:99\u2013102","journal-title":"Chest"},{"key":"1744_CR10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360:1131\u20131135","journal-title":"Lancet"},{"key":"1744_CR11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804\u2013815","journal-title":"N Engl J Med"},{"key":"1744_CR12","doi-asserted-by":"crossref","unstructured":"Wierda WG (2006) Current and investigational therapies for patients with CLL. Hematology Am Soc Hematol Educ Program 285\u201394","DOI":"10.1182\/asheducation-2006.1.285"},{"key":"1744_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","volume":"23","author":"VA Morrison","year":"2010","unstructured":"Morrison VA (2010) Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 23:145\u2013153","journal-title":"Best Pract Res Clin Haematol"},{"key":"1744_CR14","doi-asserted-by":"crossref","unstructured":"Lepretre S, Aurran T, Mah\u00e9 B et al (2012) Excess mortality following FCCam treatment in previously untreated patients with CLL: safety and efficacy in a randomized, multicenter, phase III trial. Blood. doi: 10.1182\/blood-2011-07-365437","DOI":"10.1182\/blood-2011-07-365437"},{"key":"1744_CR15","first-page":"CD008078","volume":"2","author":"N Skoetz","year":"2012","unstructured":"Skoetz N, Bauer K, Elter T et al (2012) Alemtuzumab for patients with chronic lymphocytic leukaemia. Cochrane Database Syst Rev 2:CD008078","journal-title":"Cochrane Database Syst Rev"},{"key":"1744_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","volume":"83","author":"E Azoulay","year":"2004","unstructured":"Azoulay E, Thi\u00e9ry G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Med (Baltimore) 83:360\u2013370","journal-title":"Med (Baltimore)"},{"key":"1744_CR17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-008-1320-4","volume":"35","author":"V Peigne","year":"2009","unstructured":"Peigne V, Rusinov\u00e1 K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512\u2013518","journal-title":"Intensive Care Med"},{"key":"1744_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198\u2013206","journal-title":"Cancer"},{"key":"1744_CR19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jama.1996.03540100046027","volume":"276","author":"JR Gall Le","year":"1996","unstructured":"Le Gall JR, Klar J, Lemeshow S et al (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:802\u2013810","journal-title":"JAMA"},{"key":"1744_CR20","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/00003246-199711000-00014","volume":"25","author":"DJ Muckart","year":"1997","unstructured":"Muckart DJ, Bhagwanjee S (1997) American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 25:1789\u20131795","journal-title":"Crit Care Med"},{"key":"1744_CR21","unstructured":"Anonymous (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152:S77\u2013121"},{"key":"1744_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","volume":"40","author":"M Legrand","year":"2012","unstructured":"Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43\u201349","journal-title":"Crit Care Med"},{"key":"1744_CR23","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00134-006-0354-8","volume":"32","author":"P Depuydt","year":"2006","unstructured":"Depuydt P, Benoit D, Vogelaers D et al (2006) Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 32:1773\u20131781","journal-title":"Intensive Care Med"},{"key":"1744_CR24","doi-asserted-by":"crossref","unstructured":"Morrison VA (2007) Management of infectious complications in patients with chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 332\u20138","DOI":"10.1182\/asheducation-2007.1.332"},{"key":"1744_CR25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/cncr.22094","volume":"107","author":"S Francis","year":"2006","unstructured":"Francis S, Karanth M, Pratt G et al (2006) The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer 107:1023\u20131033","journal-title":"Cancer"},{"key":"1744_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00262-005-0015-8","volume":"55","author":"F Ravandi","year":"2006","unstructured":"Ravandi F, O\u2019Brien S (2006) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother 55:197\u2013209","journal-title":"Cancer Immunol Immunother"},{"key":"1744_CR27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.seminoncol.2005.12.013","volume":"33","author":"PD Wadhwa","year":"2006","unstructured":"Wadhwa PD, Morrison VA (2006) Infectious complications of chronic lymphocytic leukemia. Semin Oncol 33:240\u2013249","journal-title":"Semin Oncol"},{"key":"1744_CR28","first-page":"374","volume":"78","author":"S Molica","year":"1993","unstructured":"Molica S, Levato D, Levato L (1993) Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up. Haematologica 78:374\u2013377","journal-title":"Haematologica"},{"key":"1744_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2141.2006.06382.x","volume":"136","author":"BF Eichhorst","year":"2007","unstructured":"Eichhorst BF, Busch R, Schweighofer C et al (2007) Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. Br J Haematol 136:63\u201372","journal-title":"Br J Haematol"},{"key":"1744_CR30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2003.04497.x","volume":"122","author":"M Hensel","year":"2003","unstructured":"Hensel M, Kornacker M, Yammeni S et al (2003) Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia. Br J Haematol 122:600\u2013606","journal-title":"Br J Haematol"},{"key":"1744_CR31","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1200\/JCO.2010.29.7978","volume":"28","author":"TS Lin","year":"2010","unstructured":"Lin TS, Donohue KA, Byrd JC et al (2010) Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101. J Clin Oncol 28:4500\u20134506","journal-title":"J Clin Oncol"},{"key":"1744_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2008.07394.x","volume":"144","author":"CD Schweighofer","year":"2009","unstructured":"Schweighofer CD, Ritgen M, Eichhorst BF et al (2009) Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG). Br J Haematol 144:95\u201398","journal-title":"Br J Haematol"},{"key":"1744_CR33","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2011-03-341032","volume":"118","author":"XC Badoux","year":"2011","unstructured":"Badoux XC, Keating MJ, Wang X et al (2011) Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. Blood 118:2085\u20132093","journal-title":"Blood"},{"key":"1744_CR34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3324\/haematol.2010.031583","volume":"96","author":"P Schellongowski","year":"2011","unstructured":"Schellongowski P, Staudinger T, Kundi M et al (2011) Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 96:231\u2013237","journal-title":"Haematologica"},{"key":"1744_CR35","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/cncr.23394","volume":"112","author":"SG Thakkar","year":"2008","unstructured":"Thakkar SG, Fu AZ, Sweetenham JW, Mciver ZA et al (2008) Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer 112:2233\u20132240","journal-title":"Cancer"},{"key":"1744_CR36","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00134-002-1528-7","volume":"28","author":"M Darmon","year":"2002","unstructured":"Darmon M, Azoulay E, Alberti C et al (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 28:1775\u20131780","journal-title":"Intensive Care Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1744-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:40:30Z","timestamp":1562683230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1744-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}